1. Home
  2. ICUI vs TNL Comparison

ICUI vs TNL Comparison

Compare ICUI & TNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUI
  • TNL
  • Stock Information
  • Founded
  • ICUI 1984
  • TNL 1990
  • Country
  • ICUI United States
  • TNL United States
  • Employees
  • ICUI N/A
  • TNL N/A
  • Industry
  • ICUI Medical/Dental Instruments
  • TNL Hotels/Resorts
  • Sector
  • ICUI Health Care
  • TNL Consumer Discretionary
  • Exchange
  • ICUI Nasdaq
  • TNL Nasdaq
  • Market Cap
  • ICUI 3.4B
  • TNL 2.9B
  • IPO Year
  • ICUI 1992
  • TNL N/A
  • Fundamental
  • Price
  • ICUI $134.86
  • TNL $48.54
  • Analyst Decision
  • ICUI Strong Buy
  • TNL Buy
  • Analyst Count
  • ICUI 5
  • TNL 10
  • Target Price
  • ICUI $196.75
  • TNL $59.20
  • AVG Volume (30 Days)
  • ICUI 283.6K
  • TNL 613.9K
  • Earning Date
  • ICUI 05-08-2025
  • TNL 07-23-2025
  • Dividend Yield
  • ICUI N/A
  • TNL 4.61%
  • EPS Growth
  • ICUI N/A
  • TNL 10.67
  • EPS
  • ICUI N/A
  • TNL 5.99
  • Revenue
  • ICUI $2,420,093,000.00
  • TNL $3,882,000,000.00
  • Revenue This Year
  • ICUI N/A
  • TNL $4.04
  • Revenue Next Year
  • ICUI N/A
  • TNL $3.73
  • P/E Ratio
  • ICUI N/A
  • TNL $8.80
  • Revenue Growth
  • ICUI 7.22
  • TNL 2.51
  • 52 Week Low
  • ICUI $101.44
  • TNL $37.77
  • 52 Week High
  • ICUI $196.26
  • TNL $58.95
  • Technical
  • Relative Strength Index (RSI)
  • ICUI 48.47
  • TNL 53.69
  • Support Level
  • ICUI $127.91
  • TNL $48.07
  • Resistance Level
  • ICUI $135.62
  • TNL $49.09
  • Average True Range (ATR)
  • ICUI 4.35
  • TNL 0.99
  • MACD
  • ICUI -0.26
  • TNL -0.22
  • Stochastic Oscillator
  • ICUI 33.77
  • TNL 36.38

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

About TNL Travel Leisure Co. Common Stock

Travel+Leisure Co is a membership and leisure travel company. It provides hospitality services and travel products. The company operates in the segments of Vacation Ownership, which is the key revenue-driving segment, develops, markets and sells vacation ownership interests (VOIs) to individual consumers, provides consumer financing in connection with the sale of VOIs, and provides property management services at resorts, and Travel and Membership which operates a variety of travel businesses, including three vacation exchange brands, a home exchange network, travel technology platforms, travel memberships, and direct-to-consumer rentals. The majority of the revenue is earned from the United States.

Share on Social Networks: